2026年全球低劑量電腦斷層掃描（CT）肺癌篩檢計畫市場報告

近年來，低劑量電腦斷層掃描（CT）肺癌篩檢計畫的市場規模迅速擴張。預計該市場規模將從2025年的16.6億美元成長到2026年的18.4億美元，複合年成長率（CAGR）為10.7%。過去幾年成長要素包括肺癌患者數量的增加、人們對早期癌症檢測意識的提高、臨床指南中相關建議的擴展、醫院篩檢系統的改進以及醫療費用報銷支持的增強。

預計未來幾年低劑量電腦斷層掃描（CT）肺癌篩檢計畫的市場規模將快速成長，到2030年將達到27.8億美元，複合年成長率（CAGR）為10.9%。預測期內的成長預計將受到以下因素的推動：人工智慧驅動的CT篩檢的日益普及、精準腫瘤學舉措的擴展、行動醫療服務模式投資的增加、遠端醫療諮詢服務整合的加速以及預防醫學領域公私合營的拓展。預測期內的關鍵趨勢包括：政府主導的肺癌篩檢計畫擴大、行動篩檢車在農村地區的部署增加、篩檢服務與戒菸支持相結合的推進、對基於風險的患者識別的日益重視以及放射影像和隨訪監測服務的擴展。

肺癌負擔日益加重預計將在未來幾年推動低劑量電腦斷層掃描（CT）肺癌篩檢計畫市場的成長。肺癌是一種起源於肺組織的惡性腫瘤，其特徵是異常細胞不受控制地增殖，且通常在發展到晚期之前沒有任何症狀。肺癌發生率的上升主要歸因於長期吸煙，以及其他因素，例如空氣污染和職業致癌物質暴露。低劑量CT肺癌篩檢計畫在肺癌管理中至關重要，因為它們能夠早期發現高風險族群（尤其是長期吸菸者）的腫瘤。例如，根據澳洲政府統計，2025年將通報約15,108例新增肺癌病例，佔所有新增癌症診斷的9.0%。因此，肺癌負擔日益加重正在推動低劑量電腦斷層掃描（CT）肺癌篩檢計畫市場的擴張。

在低劑量電腦斷層掃描（CT）肺癌篩檢專案市場中，領先企業正致力於開發先進的解決方案，例如人工智慧（AI）驅動的結節檢測，以增強早期癌症檢測能力、提高診斷準確性並簡化患者照護。 AI驅動的結節檢測是指在肺癌篩檢計畫中運用機器學習演算法，自動辨識、表徵和優先排序低劑量電腦斷層掃描上的肺結節，從而實現及時的追蹤和介入。例如，總部位於美國的醫療保健系統埃默里醫療保健（Emory Healthcare）於2025年12月啟動了埃默里醫療保健肺癌篩檢和結節項目，該項目將低劑量CT篩檢與AI增強的成像技術相結合。該計畫透過整合先進的診斷和治療能力（例如機器人輔助支氣管鏡檢查、微創肺癌手術和協作式護理導航），支持多學科診療，並在亞特蘭大都市區多個地點加速早期診斷、個人化治療方案製定和改善患者預後。

目錄

第1章執行摘要

第2章 市場特徵

• 市場定義和範圍
• 市場區隔
• 主要產品和服務概述
• 全球低劑量電腦斷層掃描（CT）肺癌篩檢計畫市場：吸引力評分及分析
• 成長潛力分析、競爭評估、策略適宜性評估、風險狀況評估

第3章 市場供應鏈分析

• 供應鏈與生態系概述
• 清單：主要原料、資源和供應商
• 主要經銷商和通路合作夥伴名單
• 主要最終用戶列表

第4章：全球市場趨勢與策略

• 關鍵科技與未來趨勢
  • 人工智慧和自主智慧
  • 生物技術、基因組學和精準醫療
  • 數位化、雲端運算、巨量資料、網路安全
  • 擴展客製化資料擷取解決方案，以滿足小眾資料需求。
  • 身臨其境型技術（AR/VR/XR）與數位體驗
• 主要趨勢
  • 擴大政府主導的肺癌篩檢計劃
  • 擴大在農村地區引入行動篩檢單元的範圍
  • 將戒菸支持服務納入健康體檢服務的進程正在推進。
  • 人們對基於風險的患者識別越來越感興趣。
  • 放射診斷和後續觀察服務的擴展

第5章 終端用戶產業市場分析

• 醫院和全科診所
• 獨立診斷影像中心
• 政府和公共衛生機構
• 私人醫療網路及保險公司
• 雇主和企業健康計劃

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及 COVID-19 疫情對市場的影響。

第7章：全球策略分析架構、目前市場規模、市場對比及成長率分析

• 全球低劑量電腦斷層掃描（CT）肺癌篩檢計畫市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
• 全球低劑量電腦斷層掃描（CT）肺癌篩檢計畫市場：規模、對比及成長率分析
• 全球低劑量電腦斷層掃描（CT）肺癌篩檢計畫市場表現：規模與成長，2020-2025年
• 全球低劑量電腦斷層掃描（CT）肺癌篩檢計畫市場預測：規模和成長，2025-2030年，2035年

第8章：全球市場總規模（TAM）

第9章 市場細分

• 按類型
• 醫院設施、獨立診斷影像中心、行動醫療檢查車
• 按服務
• 篩檢服務、診斷追蹤服務、放射影像服務、病患識別和風險評估服務、專案管理服務、遠端醫療和遠距會診服務
• 透過技術
• 標準低劑量 CT篩檢、人工智慧輔助/電腦輔助檢測 (CAD)篩檢以及全面戒菸和篩檢計畫。
• 透過使用
• 早期發現、風險評估和後續觀察。
• 最終用戶
• 醫院和多專科診所、獨立影像中心、行動篩檢服務供應商、政府和公共衛生機構、私人醫療保健網路和保險公司、雇主和企業健康計畫、學術和研究機構以及社區醫療保健中心。
• 按類型細分：醫院
• 門診、住院、放射科
• 按類型細分：獨立診斷影像中心
• 獨立影像診斷診所、診斷中心、肺癌專科篩檢中心
• 按類型細分：行動篩檢單元
• 巴士式篩檢裝置、廂式篩檢裝置、臨時快閃篩檢裝置

第10章 區域與國別分析

第11章 亞太市場

第12章：中國市場

第13章：印度市場

第14章：日本市場

第15章：澳洲市場

第16章：印尼市場

第17章：韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章 西歐市場

第21章英國市場

第22章：德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章：東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章：南美市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

• 低劑量電腦斷層掃描（CT）肺癌篩檢計畫市場：競爭格局和市場佔有率，2024年
• 低劑量電腦斷層掃描（CT）肺癌篩檢專案市場：公司估值矩陣
• 低劑量電腦斷層掃描（CT）肺癌篩檢計畫市場：公司概況
  • Hitachi Medical Systems America Inc.
  • Medtronic plc
  • Siemens Healthineers AG
  • Koninklijke Philips NV
  • GE HealthCare Inc.

第37章 其他大型企業和創新企業

• Mayo Clinic, Columbia University Herbert Irving Comprehensive Cancer Center, Duke University Health System, Emory Healthcare, Canon Medical Systems Corporation, RadNet Inc., University of Tennessee Medical Center, McLeod Health, Holy Cross Health, Lima Memorial Health System, Memorial Sloan Kettering Cancer Center, Independence Health System, Weill Cornell Medicine & NewYork-Presbyterian Mobile Unit, Optellum Ltd., 4DMedical Pty Ltd.

第38章：全球市場競爭基準分析與儀錶板

第39章：預計進入市場的新創企業

第40章 重大併購

第41章 具有高市場潛力的國家、細分市場與策略

• 低劑量電腦斷層掃描（CT）肺癌篩檢計畫市場展望（2030）：提供新機會的國家
• 低劑量電腦斷層掃描（CT）肺癌篩檢計畫市場，2030 年：提供新機會的細分市場
• 低劑量電腦斷層掃描（CT）肺癌篩檢計畫市場展望（2030年）：成長策略
  • 基於市場趨勢的策略
  • 競爭對手的策略

第42章附錄

Low-dose computed tomography (CT) lung screening programs are preventive healthcare initiatives that utilize low-dose CT imaging to identify lung abnormalities at an early stage. These programs facilitate the detection of small nodules or possible malignancies before the onset of symptoms, thereby enhancing the likelihood of effective and successful treatment.

The main types of low-dose computed tomography (CT) lung screening programs consist of hospital-based programs, independent imaging centers, and mobile screening units. Hospital-based programs are structured screening initiatives conducted within hospitals to identify lung abnormalities at an early stage and enhance patient outcomes. These programs provide services including screening services, diagnostic follow-up services, radiology interpretation services, patient identification and risk assessment services, program management services, as well as telehealth and remote consultation services, and they employ technologies such as standard low-dose CT screening, AI-assisted/computer-aided detection (CAD) screening, and integrated smoking cessation and screening programs. The different applications covered include early detection, risk assessment, and follow-up monitoring, and they are utilized by various end users including hospitals and multi-specialty clinics, standalone diagnostic imaging centers, mobile screening service providers, government and public health agencies, private healthcare networks and insurance providers, employer and corporate wellness programs, academic and research institutions, and community health centers.

Tariffs on imported CT scanners, imaging components, and semiconductor-based diagnostic equipment have increased capital costs for low-dose CT lung screening programs, particularly affecting hospital-based and independent imaging center segments. Regions such as North America and Europe that rely on globally sourced imaging hardware are most impacted, especially for AI-assisted and advanced screening technologies. Higher equipment costs may slow expansion in cost-sensitive public health programs; however, tariffs are also encouraging domestic manufacturing of imaging systems, strengthening regional supply chains, and promoting innovation in cost-efficient low-dose CT technologies.

The low-dose computed tomography (CT) lung screening programs market research report is one of a series of new reports from The Business Research Company that provides low-dose computed tomography (CT) lung screening programs market statistics, including low-dose computed tomography (CT) lung screening programs industry global market size, regional shares, competitors with a low-dose computed tomography (CT) lung screening programs market share, detailed low-dose computed tomography (CT) lung screening programs market segments, market trends and opportunities, and any further data you may need to thrive in the low-dose computed tomography (CT) lung screening programs industry. This low-dose computed tomography (CT) lung screening programs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The low-dose computed tomography (CT) lung screening programs market size has grown rapidly in recent years. It will grow from $1.66 billion in 2025 to $1.84 billion in 2026 at a compound annual growth rate (CAGR) of 10.7%. The growth in the historic period can be attributed to rising prevalence of lung cancer cases, increasing awareness about early cancer detection, growing recommendations from clinical guidelines, expansion of hospital-based screening infrastructure, increasing healthcare reimbursement support.

The low-dose computed tomography (CT) lung screening programs market size is expected to see rapid growth in the next few years. It will grow to $2.78 billion in 2030 at a compound annual growth rate (CAGR) of 10.9%. The growth in the forecast period can be attributed to growing adoption of AI-assisted CT screening, expansion of precision oncology initiatives, rising investment in mobile healthcare delivery models, increasing integration of telehealth consultation services, expanding public-private partnerships in preventive healthcare. Major trends in the forecast period include expansion of government-sponsored lung cancer screening programs, increasing adoption of mobile screening units in rural areas, rising integration of smoking cessation support with screening services, growing emphasis on risk-based patient identification, expansion of radiology interpretation and follow-up monitoring services.

The increasing burden of lung cancer is anticipated to propel the growth of the low-dose computed tomography (CT) lung screening programs market in the coming years. Lung cancer is a type of malignancy that develops in lung tissue and is marked by the uncontrolled proliferation of abnormal cells, often remaining without symptoms until reaching advanced stages. The growing occurrence of lung cancer is largely attributed to prolonged tobacco use, along with other contributing factors such as exposure to air pollution and occupational carcinogens. Low-dose CT lung screening programs are essential in lung cancer management as they allow for the early identification of tumors in high-risk groups, particularly long-term smokers. For example, in February 2026, according to the Australian Government, an Australia-based government department, approximately 15,108 new lung cancer cases were reported in 2025, representing 9.0% of all new cancer diagnoses. Consequently, the escalating burden of lung cancer is driving the expansion of the low-dose computed tomography (CT) lung screening programs market.

Key companies operating in the low-dose computed tomography (CT) lung screening programs market are focusing on developing advanced solutions, such as artificial intelligence (AI)-assisted nodule detection, to enhance early cancer detection, improve diagnostic accuracy, and streamline patient care. AI-assisted nodule detection refers to the use of machine-learning algorithms within lung screening programs to automatically identify, characterize, and prioritize pulmonary nodules on low-dose CT scans, enabling timely follow-up and intervention. For example, in December 2025, Emory Healthcare, a US-based health system, launched the Emory Healthcare Lung Screening and Nodule Program, which integrates low-dose CT screening with AI-enhanced imaging technology. The program supports multidisciplinary care by incorporating advanced diagnostic and treatment capabilities, including robot-assisted bronchoscopy, minimally invasive lung cancer surgery, and coordinated care navigation, facilitating early diagnosis, personalized treatment planning, and improved patient outcomes across multiple metro Atlanta locations.

In September 2023, AstraZeneca, a UK-based company that delivers and supports initiatives promoting low-dose CT (LDCT) lung screening, formed a partnership with Institute Kanser Negara. Through this collaboration, AstraZeneca and Institute Kanser Negara aim to utilize artificial intelligence technology to improve the accuracy, efficiency, and early detection capabilities of low-dose CT lung screening programs. Institute Kanser Negara, a Malaysia-based, provides Low-Dose CT (LDCT) lung screening programs.

Major companies operating in the low-dose computed tomography (CT) lung screening programs market are Hitachi Medical Systems America Inc., Medtronic plc, Siemens Healthineers AG, Koninklijke Philips N.V., GE HealthCare Inc., Mayo Clinic, Columbia University Herbert Irving Comprehensive Cancer Center, Duke University Health System, Emory Healthcare, Canon Medical Systems Corporation, RadNet Inc., University of Tennessee Medical Center, McLeod Health, Holy Cross Health, Lima Memorial Health System, Memorial Sloan Kettering Cancer Center, Independence Health System, Weill Cornell Medicine & NewYork-Presbyterian Mobile Unit, Optellum Ltd., 4DMedical Pty Ltd.

North America was the largest region in the low-dose computed tomography (CT) lung screening programs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the low-dose computed tomography (CT) lung screening programs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the low-dose computed tomography (CT) lung screening programs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The low-dose computed tomography (CT) lung screening programs market consists of revenues earned by entities by providing services such as follow-up monitoring, risk assessment, and referral coordination. The market value includes the value of related goods sold by the service provider or included within the service offering. The low-dose computed tomography (CT) lung screening programs market includes sales of lung phantoms, protective shielding, and patient positioning aids. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Low-Dose Computed Tomography (CT) Lung Screening Programs Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses low-dose computed tomography (ct) lung screening programs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for low-dose computed tomography (ct) lung screening programs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The low-dose computed tomography (ct) lung screening programs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Type: Hospital-Based; Independent Imaging Centers; Mobile Screening Units
• 2) By Service: Screening Services; Diagnostic Follow-Up Services; Radiology Interpretation Services; Patient Identification And Risk Assessment Services; Program Management Services; Telehealth And Remote Consultation Services
• 3) By Technology: Standard Low-Dose CT Screening; AI-Assisted/Computer-Aided Detection (CAD) Screening; Integrated Smoking Cessation And Screening Programs
• 4) By Application: Early Detection; Risk Assessment; Follow-Up Monitoring
• 5) By End User: Hospitals And Multi-Specialty Clinics; Standalone Diagnostic Imaging Centers; Mobile Screening Service Providers; Government And Public Health Agencies; Private Healthcare Networks And Insurance Providers; Employer And Corporate Wellness Programs; Academic And Research Institutions; Community Health Centers
• Subsegments:
• 1) By Hospital-Based: Outpatient Department; Inpatient Department; Radiology Department
• 2) By Independent Imaging Centers: Standalone Imaging Clinics; Diagnostic Centers; Specialized Lung Screening Centers
• 3) By Mobile Screening Units: Bus-Based Screening Units; Van-Based Screening Units; Temporary Pop-Up Screening Units
• Companies Mentioned: Hitachi Medical Systems America Inc.; Medtronic plc; Siemens Healthineers AG; Koninklijke Philips N.V.; GE HealthCare Inc.; Mayo Clinic; Columbia University Herbert Irving Comprehensive Cancer Center; Duke University Health System; Emory Healthcare; Canon Medical Systems Corporation; RadNet Inc.; University of Tennessee Medical Center; McLeod Health; Holy Cross Health; Lima Memorial Health System; Memorial Sloan Kettering Cancer Center; Independence Health System; Weill Cornell Medicine & NewYork-Presbyterian Mobile Unit; Optellum Ltd.; 4DMedical Pty Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Low-Dose Computed Tomography (CT) Lung Screening Programs Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Low-Dose Computed Tomography (CT) Lung Screening Programs Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Low-Dose Computed Tomography (CT) Lung Screening Programs Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Low-Dose Computed Tomography (CT) Lung Screening Programs Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Artificial Intelligence & Autonomous Intelligence
  • 4.1.2 Biotechnology, Genomics & Precision Medicine
  • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.4 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems
  • 4.1.5 Immersive Technologies (AR/VR/XR) & Digital Experiences
• 4.2. Major Trends
  • 4.2.1 Expansion of Government-Sponsored Lung Cancer Screening Programs
  • 4.2.2 Increasing Adoption of Mobile Screening Units in Rural Areas
  • 4.2.3 Rising Integration of Smoking Cessation Support with Screening Services
  • 4.2.4 Growing Emphasis on Risk-Based Patient Identification
  • 4.2.5 Expansion of Radiology Interpretation and Follow-Up Monitoring Services

5. Low-Dose Computed Tomography (CT) Lung Screening Programs Market Analysis Of End Use Industries

• 5.1 Hospitals And Multi-Specialty Clinics
• 5.2 Standalone Diagnostic Imaging Centers
• 5.3 Government And Public Health Agencies
• 5.4 Private Healthcare Networks And Insurance Providers
• 5.5 Employer And Corporate Wellness Programs

6. Low-Dose Computed Tomography (CT) Lung Screening Programs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Low-Dose Computed Tomography (CT) Lung Screening Programs Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Low-Dose Computed Tomography (CT) Lung Screening Programs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Low-Dose Computed Tomography (CT) Lung Screening Programs Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Low-Dose Computed Tomography (CT) Lung Screening Programs Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Low-Dose Computed Tomography (CT) Lung Screening Programs Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Low-Dose Computed Tomography (CT) Lung Screening Programs Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Low-Dose Computed Tomography (CT) Lung Screening Programs Market Segmentation

• 9.1. Global Low-Dose Computed Tomography (CT) Lung Screening Programs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospital-Based, Independent Imaging Centers, Mobile Screening Units
• 9.2. Global Low-Dose Computed Tomography (CT) Lung Screening Programs Market, Segmentation By Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Screening Services, Diagnostic Follow-Up Services, Radiology Interpretation Services, Patient Identification And Risk Assessment Services, Program Management Services, Telehealth And Remote Consultation Services
• 9.3. Global Low-Dose Computed Tomography (CT) Lung Screening Programs Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Standard Low-Dose CT Screening, AI-Assisted/Computer-Aided Detection (CAD) Screening, Integrated Smoking Cessation And Screening Programs
• 9.4. Global Low-Dose Computed Tomography (CT) Lung Screening Programs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Early Detection, Risk Assessment, Follow-Up Monitoring
• 9.5. Global Low-Dose Computed Tomography (CT) Lung Screening Programs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals And Multi-Specialty Clinics, Standalone Diagnostic Imaging Centers, Mobile Screening Service Providers, Government And Public Health Agencies, Private Healthcare Networks And Insurance Providers, Employer And Corporate Wellness Programs, Academic And Research Institutions, Community Health Centers
• 9.6. Global Low-Dose Computed Tomography (CT) Lung Screening Programs Market, Sub-Segmentation Of Hospital-Based, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Outpatient Department, Inpatient Department, Radiology Department
• 9.7. Global Low-Dose Computed Tomography (CT) Lung Screening Programs Market, Sub-Segmentation Of Independent Imaging Centers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Standalone Imaging Clinics, Diagnostic Centers, Specialized Lung Screening Centers
• 9.8. Global Low-Dose Computed Tomography (CT) Lung Screening Programs Market, Sub-Segmentation Of Mobile Screening Units, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Bus-Based Screening Units, Van-Based Screening Units, Temporary Pop-Up Screening Units

10. Low-Dose Computed Tomography (CT) Lung Screening Programs Market Regional And Country Analysis

• 10.1. Global Low-Dose Computed Tomography (CT) Lung Screening Programs Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Low-Dose Computed Tomography (CT) Lung Screening Programs Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Low-Dose Computed Tomography (CT) Lung Screening Programs Market

• 11.1. Asia-Pacific Low-Dose Computed Tomography (CT) Lung Screening Programs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Low-Dose Computed Tomography (CT) Lung Screening Programs Market, Segmentation By Type, Segmentation By Service, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Low-Dose Computed Tomography (CT) Lung Screening Programs Market

• 12.1. China Low-Dose Computed Tomography (CT) Lung Screening Programs Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Low-Dose Computed Tomography (CT) Lung Screening Programs Market, Segmentation By Type, Segmentation By Service, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Low-Dose Computed Tomography (CT) Lung Screening Programs Market

• 13.1. India Low-Dose Computed Tomography (CT) Lung Screening Programs Market, Segmentation By Type, Segmentation By Service, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Low-Dose Computed Tomography (CT) Lung Screening Programs Market

• 14.1. Japan Low-Dose Computed Tomography (CT) Lung Screening Programs Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Low-Dose Computed Tomography (CT) Lung Screening Programs Market, Segmentation By Type, Segmentation By Service, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Low-Dose Computed Tomography (CT) Lung Screening Programs Market

• 15.1. Australia Low-Dose Computed Tomography (CT) Lung Screening Programs Market, Segmentation By Type, Segmentation By Service, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Low-Dose Computed Tomography (CT) Lung Screening Programs Market

• 16.1. Indonesia Low-Dose Computed Tomography (CT) Lung Screening Programs Market, Segmentation By Type, Segmentation By Service, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Low-Dose Computed Tomography (CT) Lung Screening Programs Market

• 17.1. South Korea Low-Dose Computed Tomography (CT) Lung Screening Programs Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Low-Dose Computed Tomography (CT) Lung Screening Programs Market, Segmentation By Type, Segmentation By Service, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Low-Dose Computed Tomography (CT) Lung Screening Programs Market

• 18.1. Taiwan Low-Dose Computed Tomography (CT) Lung Screening Programs Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Low-Dose Computed Tomography (CT) Lung Screening Programs Market, Segmentation By Type, Segmentation By Service, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Low-Dose Computed Tomography (CT) Lung Screening Programs Market

• 19.1. South East Asia Low-Dose Computed Tomography (CT) Lung Screening Programs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Low-Dose Computed Tomography (CT) Lung Screening Programs Market, Segmentation By Type, Segmentation By Service, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Low-Dose Computed Tomography (CT) Lung Screening Programs Market

• 20.1. Western Europe Low-Dose Computed Tomography (CT) Lung Screening Programs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Low-Dose Computed Tomography (CT) Lung Screening Programs Market, Segmentation By Type, Segmentation By Service, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Low-Dose Computed Tomography (CT) Lung Screening Programs Market

• 21.1. UK Low-Dose Computed Tomography (CT) Lung Screening Programs Market, Segmentation By Type, Segmentation By Service, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Low-Dose Computed Tomography (CT) Lung Screening Programs Market

• 22.1. Germany Low-Dose Computed Tomography (CT) Lung Screening Programs Market, Segmentation By Type, Segmentation By Service, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Low-Dose Computed Tomography (CT) Lung Screening Programs Market

• 23.1. France Low-Dose Computed Tomography (CT) Lung Screening Programs Market, Segmentation By Type, Segmentation By Service, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Low-Dose Computed Tomography (CT) Lung Screening Programs Market

• 24.1. Italy Low-Dose Computed Tomography (CT) Lung Screening Programs Market, Segmentation By Type, Segmentation By Service, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Low-Dose Computed Tomography (CT) Lung Screening Programs Market

• 25.1. Spain Low-Dose Computed Tomography (CT) Lung Screening Programs Market, Segmentation By Type, Segmentation By Service, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Low-Dose Computed Tomography (CT) Lung Screening Programs Market

• 26.1. Eastern Europe Low-Dose Computed Tomography (CT) Lung Screening Programs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Low-Dose Computed Tomography (CT) Lung Screening Programs Market, Segmentation By Type, Segmentation By Service, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Low-Dose Computed Tomography (CT) Lung Screening Programs Market

• 27.1. Russia Low-Dose Computed Tomography (CT) Lung Screening Programs Market, Segmentation By Type, Segmentation By Service, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Low-Dose Computed Tomography (CT) Lung Screening Programs Market

• 28.1. North America Low-Dose Computed Tomography (CT) Lung Screening Programs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Low-Dose Computed Tomography (CT) Lung Screening Programs Market, Segmentation By Type, Segmentation By Service, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Low-Dose Computed Tomography (CT) Lung Screening Programs Market

• 29.1. USA Low-Dose Computed Tomography (CT) Lung Screening Programs Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Low-Dose Computed Tomography (CT) Lung Screening Programs Market, Segmentation By Type, Segmentation By Service, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Low-Dose Computed Tomography (CT) Lung Screening Programs Market

• 30.1. Canada Low-Dose Computed Tomography (CT) Lung Screening Programs Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Low-Dose Computed Tomography (CT) Lung Screening Programs Market, Segmentation By Type, Segmentation By Service, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Low-Dose Computed Tomography (CT) Lung Screening Programs Market

• 31.1. South America Low-Dose Computed Tomography (CT) Lung Screening Programs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Low-Dose Computed Tomography (CT) Lung Screening Programs Market, Segmentation By Type, Segmentation By Service, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Low-Dose Computed Tomography (CT) Lung Screening Programs Market

• 32.1. Brazil Low-Dose Computed Tomography (CT) Lung Screening Programs Market, Segmentation By Type, Segmentation By Service, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Low-Dose Computed Tomography (CT) Lung Screening Programs Market

• 33.1. Middle East Low-Dose Computed Tomography (CT) Lung Screening Programs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Low-Dose Computed Tomography (CT) Lung Screening Programs Market, Segmentation By Type, Segmentation By Service, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Low-Dose Computed Tomography (CT) Lung Screening Programs Market

• 34.1. Africa Low-Dose Computed Tomography (CT) Lung Screening Programs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Low-Dose Computed Tomography (CT) Lung Screening Programs Market, Segmentation By Type, Segmentation By Service, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Low-Dose Computed Tomography (CT) Lung Screening Programs Market Regulatory and Investment Landscape

36. Low-Dose Computed Tomography (CT) Lung Screening Programs Market Competitive Landscape And Company Profiles

• 36.1. Low-Dose Computed Tomography (CT) Lung Screening Programs Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Low-Dose Computed Tomography (CT) Lung Screening Programs Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Low-Dose Computed Tomography (CT) Lung Screening Programs Market Company Profiles
  • 36.3.1. Hitachi Medical Systems America Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. GE HealthCare Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Low-Dose Computed Tomography (CT) Lung Screening Programs Market Other Major And Innovative Companies

• Mayo Clinic, Columbia University Herbert Irving Comprehensive Cancer Center, Duke University Health System, Emory Healthcare, Canon Medical Systems Corporation, RadNet Inc., University of Tennessee Medical Center, McLeod Health, Holy Cross Health, Lima Memorial Health System, Memorial Sloan Kettering Cancer Center, Independence Health System, Weill Cornell Medicine & NewYork-Presbyterian Mobile Unit, Optellum Ltd., 4DMedical Pty Ltd.

38. Global Low-Dose Computed Tomography (CT) Lung Screening Programs Market Competitive Benchmarking And Dashboard

39. Upcoming Startups in the Market

40. Key Mergers And Acquisitions In The Low-Dose Computed Tomography (CT) Lung Screening Programs Market

41. Low-Dose Computed Tomography (CT) Lung Screening Programs Market High Potential Countries, Segments and Strategies

• 41.1 Low-Dose Computed Tomography (CT) Lung Screening Programs Market In 2030 - Countries Offering Most New Opportunities
• 41.2 Low-Dose Computed Tomography (CT) Lung Screening Programs Market In 2030 - Segments Offering Most New Opportunities
• 41.3 Low-Dose Computed Tomography (CT) Lung Screening Programs Market In 2030 - Growth Strategies
  • 41.3.1 Market Trend Based Strategies
  • 41.3.2 Competitor Strategies

42. Appendix

• 42.1. Abbreviations
• 42.2. Currencies
• 42.3. Historic And Forecast Inflation Rates
• 42.4. Research Inquiries
• 42.5. The Business Research Company
• 42.6. Copyright And Disclaimer